# ApoE2 and protective molecular signatures in Alzheimer's disease and aging

> **NIH NIH R01** · DUKE UNIVERSITY · 2022 · $767,155

## Abstract

Previous research emphasizes pleiotropic effects of the APOE 19q13.3 region variants supporting
protective (notably, the APOE e2 allele) and detrimental (the APOE e4 allele) roles in Alzheimer’s
disease (AD) and aging. Despite nearly two-decade progress in the APOE research, however, even
pathogenic role of the strongest risk factor for AD, the APOE e4 allele, remains poorly understood.
Understanding protective role of the e2 allele is lagged behind the APOE e4 research due to, in part,
seemingly smaller effects of this allele on AD. This paradoxical situation of a potentially strong role of
the APOE locus in AD and aging, and a hampered progress in the ApoE2-Aging-AD research requires
new approaches. Our approach is built on core principles of evolutionary biology in genetics of aging-
related traits characteristic for post-reproductive life, insights from genetic epidemiology of such traits,
and the results of our large-scale pilot study of five human cohorts proving its significance and feasibility.
The core of our approach is the association of AD with complex molecular signatures in the APOE
region, rather than with a single allele, which include the e2 allele. These signatures are defined by
significant differences in linkage disequilibrium (LD) patterns between affected and unaffected subjects.
The principal difference between our approach and previous studies of LD structures in the APOE
region, making it highly innovative, is that following the core biological principles in genetics of aging-
related traits, the effects in the ApoE2-Aging-AD framework are considered to be associated with AD-
specific molecular signatures, rather than with those driven by common evolutionarily forces. This
difference justifies the focus on extended signatures comprised of the APOE e2 allele and SNPs spread
through the entire genome and interacting with this allele. Analysis of molecular signatures provides
invaluable opportunity to dissect heterogeneity in action of the APOE e2 allele by identifying
personalized (i.e., more homogeneous, group specific) polygenic profiles with stronger protective effect
of this allele. The objective of this proposal is to identify personalized polygenic profiles, comprised of
the e2 allele, other SNPs in the APOE region, and SNPs spread through the entire genome, with
stronger protection in the ApoE2-Aging-AD framework, and identify the role of AD risk factors in these
profiles. Specific aims: Aim 1. Identify molecular signatures of AD and life span as a proxy for aging.
Aim 2. Dissect heterogeneity and identify commonalities in the molecular signatures. Aim 3. Identify
personalized polygenic profiles of AD and aging traits. Aim 4. Use bioinformatics analysis to
characterize functional consequences of SNPs and genes.

## Key facts

- **NIH application ID:** 10425329
- **Project number:** 5R01AG061853-05
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** ALEXANDER M KULMINSKI
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $767,155
- **Award type:** 5
- **Project period:** 2018-09-30 → 2025-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10425329

## Citation

> US National Institutes of Health, RePORTER application 10425329, ApoE2 and protective molecular signatures in Alzheimer's disease and aging (5R01AG061853-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10425329. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*